New First-Line Options for ALK-Positive Lung Cancer on the Horizon
The ASCO Post,
Advertisement The prolonged front-line progression-free survival seen with second-generation inhibitors, coupled with…
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK
Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, April 2011
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Readers on
- mendeley
- 272 Mendeley
- citeulike
- 2 CiteULike